rs-0139
rs oncology
['rs-0139']
day 3 at #esmo22 and it's been an extraordinary experience with so much to learn and share already! is at hall4 presenting our poster on rs-0139's phase ia/ib study, recently got the green light for dose escalation 
BAL’98 //EÜTF’04 // MD & Founder @misPHARMA // Medical Director & Board Member @RS_Research_TR